Trial Reveals Long-Term Success of First-Line Rituximab Treatment for Pemphigus Patients
In a revolutionary development for pemphigus treatment, a 7-year follow-up study of the Ritux 3 trial has unveiled the remarkable long-term efficacy and safety of a first-line treatment approach utilizing rituximab. The findings of this trial, conducted across 25 dermatology departments in France, offer a promising breakthrough supporting the efficacy and safety of the Ritux […]